10 small-cap stocks everyone's watching

The stock market is buzzing with a cast of characters that have recently stolen the spotlight. From surprise takeovers to industry shake-ups, these ten companies are the talk of Dalal Street. Below we present a lively rundown of why each stock is making news, coupled with key price stats and Value Research ratings to keep it factual. Grab some chai, and let's dive into the frenzy! NACL Industries NACL Industries has been seasoning its stock chart with some serious spice. The agrochemical player saw its shares rocket amid buzz that Murugappa Group's Coromandel International is taking a controlling stake. Investors are salivating at the turnaround potential - after all, a dose of Murugappa magic can make even a salt (NaCl) producer taste sweet. It doesn't hurt that NACL hit upper-circuit levels for days, fueled by a 53 per cent buyout deal at Rs 76 a share (far below its current market price!). Talk about a deal leaving everyone thirsty for more. Most recent price (Apr 11, 2025): Rs 163.94 52-week range: Rs 49.00 - Rs 163.94 Value Research Ratings: 2★; Quality - 1/10; Growth - 5/10; Valuation - 1/10; Momentum - 10/10 Mangalore Chemicals & Fertilizers This fertiliser firm has been fertilising portfolios with rich returns. Mangalore Chemicals' stock bloomed to an all-time high of Rs 191.75, riding on the back of stellar earnings and sector tailwinds. In an era of global food inflation, anything related to fertilisers smells like profit, and this company's performance has been as strong as the odor of ammonia. Traders joked that the stock has "outgrown its pot," and indeed, with such growth, one might need a bigger basket to hold these gains. Most recent price (Apr 11, 2025): Rs 188.72 52-week range: Rs 94.40 - Rs 191.75 Value Research Ratings: 4★; Quality - 4/10; Growth - 8/10; Valuation - 6/10; Momentum - 10/10 Laurus Labs After a rough bout, Laurus Labs is back in the lab, formulating a comeback. This pharma player went from market darling to dud, plunging from a peak of ~Rs 707 in 2021 to ~Rs 397 by end-2023 as margin pressures bit. But 2025 has seen a reversal of fortunes: a strong pickup in its custom manufacturing (CDMO) business and easing headwinds in core s